相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service
James L. Martin et al.
PHARMACOGENOMICS (2022)
A Scoping Review of Attitudes and Experiences with Pharmacogenomic Testing among Patients and the General Public: Implications for Patient Counseling
Josiah D. Allen et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors
Oluwole Adeyemi Babatunde et al.
DISEASES (2022)
PGx in psychiatry: Patients' knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing
Amanda Kastrinos et al.
PATIENT EDUCATION AND COUNSELING (2021)
Sociodemographic factors and beliefs about medicines in the uptake of pharmacogenomic testing in older adults
Alexandra Chapdelaine et al.
PHARMACOGENOMICS (2021)
Association between Neighborhood Social Deprivation and Stage at Diagnosis among Breast Cancer Patients in South Carolina
Oluwole Adeyemi Babatunde et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Precision medicine in 2030-seven ways to transform healthcare
Joshua C. Denny et al.
CELL (2021)
Patients with geographic barriers to health care access are prescribed a higher proportion of drugs with pharmacogenetic testing guidelines
Rachel Dalton et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics
Loren Saulsberry et al.
NPJ GENOMIC MEDICINE (2021)
Trends in health equity in mortality in the United States, 1969-2019
Nathaniel W. Anderson et al.
SSM-POPULATION HEALTH (2021)
Medical innovations can reduce social inequalities in health: an analysis of blood pressure and medication in the HUNT study
Havard T. Rydland
HEALTH SOCIOLOGY REVIEW (2021)
Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study
Dean A. Regier et al.
PHARMACOECONOMICS (2020)
Coverage of pharmacogenetic tests by private health insurance companies
Sharon K. Park et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2020)
An assessment of patient perspectives on pharmacogenomics educational materials
Gladys B. Asiedu et al.
PHARMACOGENOMICS (2020)
Excess 30-Day Heart Failure Readmissions and Mortality in Black Patients Increases With Neighborhood Deprivation
Shivani A. Patel et al.
CIRCULATION-HEART FAILURE (2020)
The Uneven Distribution of Medically Underserved Areas in Chicago
Sage J. Kim et al.
HEALTH EQUITY (2020)
Characteristics of telehealth users in NYC for COVID-related care during the coronavirus pandemic
Ellerie Weber et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2020)
Rural Community Perceptions and Interests in Pharmacogenomics
John Stegelmeier et al.
HEALTHCARE (2020)
The Missing Diversity in Human Genetic Studies
Giorgio Sirugo et al.
CELL (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients
Marie-Pier Frigon et al.
PHARMACOGENOMICS (2019)
Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: Systematic review
Juan R. Canedo et al.
JOURNAL OF GENETIC COUNSELING (2019)
Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group
Lori A. Orlando et al.
GENETICS IN MEDICINE (2018)
Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population
Yee Ming Lee et al.
PHARMACOTHERAPY (2018)
Innovative technologies and social inequalities in health: A scoping review of the literature
Daniel Weiss et al.
PLOS ONE (2018)
Self-Identified Social Determinants of Health during Transitions of Care in the Medically Underserved: a Narrative Review
Anunta Virapongse et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
Qualitative user evaluation of a revised pharmacogenetic educational toolkit
Rachel Mills et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)
Are patients willing to incur out-of-pocket costs for pharmacogenomic testing?
S. J. Bielinski et al.
PHARMACOGENOMICS JOURNAL (2017)
Attention by design: Using attention checks to detect inattentive respondents and improve data quality
James D. Abbey et al.
JOURNAL OF OPERATIONS MANAGEMENT (2017)
An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review
Antony Martin et al.
PHARMACOGENOMICS (2017)
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice
Marc B. Rosenman et al.
VALUE IN HEALTH (2017)
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network
Nina R. Sperber et al.
BMC MEDICAL GENOMICS (2017)
Development and Initial Assessment of a Patient Education Video about Pharmacogenetics
Rachel Mills et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
The Association Between Income and Life Expectancy in the United States, 2001-2014
Raj Chetty et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients
K. Lachance et al.
PHARMACOGENOMICS JOURNAL (2015)
Public attitudes towards genetic testing revisited: comparing opinions between 2002 and 2010
Lidewij Henneman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Public Knowledge of and Attitudes Toward Genetics and Genetic Testing
Susanne B. Haga et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2013)
Measures of Social Deprivation That Predict Health Care Access and Need within a Rational Area of Primary Care Service Delivery
Danielle C. Butler et al.
HEALTH SERVICES RESEARCH (2013)
'Generic to genetic' transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine
Jorge Duconge et al.
PHARMACOGENOMICS (2012)
Assessing Internet access and use in a medically underserved population: implications for providing enhanced health information services
Lisl Zach et al.
HEALTH INFORMATION AND LIBRARIES JOURNAL (2012)
Views on Personalized Medicine: Do the Attitudes of African American and White Prescription Drug Consumers Differ?
M. De Marco
PUBLIC HEALTH GENOMICS (2010)
Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population
J. O'Daniel et al.
PUBLIC HEALTH GENOMICS (2010)
Designating places and Populations as medically underserved: A proposal for a new approach
Thomas C. Ricketts et al.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2007)
Patients' and physicians' perspectives on pharmacogenetic testing
A Rogausch et al.
PHARMACOGENOMICS (2006)
Explaining trends in inequities: evidence from Brazilian child health studies
CG Victora et al.
LANCET (2000)
分享论文
